Neuroendocrine study of a male infant with septo-optic dysplasia
- PMID: 3877029
Neuroendocrine study of a male infant with septo-optic dysplasia
Abstract
Septo-optic dysplasia includes abnormalities of the optic nerves and tracts with absence of the septum pellucidum. Most of the recently reported patients were deficient in growth hormone. We describe a male infant with septo-optic dysplasia in whom extensive endocrine evaluation revealed central diabetes insipidus, hypothalamic hypothyroidism and combined (hypothalamic-pituitary) hypoadrenalism, along with normal pituitary growth hormone reserve. This is the first reported case of a patient with septo-optic dysplasia who underwent corticotropin-releasing factor and growth hormone-releasing hormone stimulation.
Similar articles
-
Hormonal, metabolic, and neuroradiologic abnormalities associated with septo-optic dysplasia.Acta Endocrinol (Copenh). 1984 Oct;107(2):282-8. doi: 10.1530/acta.0.1070282. Acta Endocrinol (Copenh). 1984. PMID: 6093418
-
The endocrine spectrum of septo-optic dysplasia.Clin Pediatr (Phila). 1984 Nov;23(11):632-6. doi: 10.1177/000992288402301105. Clin Pediatr (Phila). 1984. PMID: 6488662
-
[Septo-optic dysplasia with antidiuretic hormone deficiency and central adrenocortical insufficiency. Three cases report in infants (author's transl)].Nouv Presse Med. 1978 Oct 28;7(37):3327-31. Nouv Presse Med. 1978. PMID: 733502 French.
-
Optic nerve hypoplasia: septo-optic-pituitary dysplasia syndrome.Trans Am Ophthalmol Soc. 1981;79:425-57. Trans Am Ophthalmol Soc. 1981. PMID: 7043865 Free PMC article. Review.
-
Septo-optic dysplasia associated with polyendocrine dysfunction.J Med. 1993;24(1):67-74. J Med. 1993. PMID: 8501404 Review.